Results 11 to 20 of about 430,558 (143)

Correlation of CA-125 with different stages of endometriosis

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2018
This study was conducted to evaluate the association of serum cancer antigen (CA-125) level with the severity of pelvic endometriosis. Seventy diagnosed cases of pelvic endometriosis were included in this study.
Runa Laila   +3 more
doaj   +1 more source

Immunohistochemistry of CA 125

open access: yesThe International Journal of Biological Markers, 1998
CA 125 is known as the marker that is most strongly associated with epithelial gynecological tumors. Compared to the number of publications on its use in serum assays, the application in immunohistochemistry is still limited.
M. Nap
doaj   +1 more source

Yüksek Serum CA19-9 Seviyeleri ile Seyreden Bir Endometriozis Olgusu

open access: yesSakarya Tıp Dergisi, 2019
CA19-9 özellikle safra kanalı ve pankreas kanserlerinde yüksek olarak saptanan bir tümör belirtecidir. Bu durumlara ek olarak kolon, mide, over, karaciğer ve özafagus kanserleri gibi diğer malign durumlarda da yüksek seviyelerde saptanır.CA19-9 pankreas ...
Özlem Nuray Sever, Dilahan Şankır
doaj   +1 more source

Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors

open access: yesClinical and Translational Science, 2023
Increasing demand for glutaminase (GLS) due to high rates of glutamine metabolism is considered one of the hallmarks of malignancy. In parallel, cancer antigen 125 (CA‐125) is a commonly used ovarian tumor marker. This study aimed to compare the roles of
Gatot Nyarumenteng Adhipurnawan Winarno   +9 more
doaj   +1 more source

Plasma carbohydrate antigen-125 for prediction of atrial fibrillation recurrence after radiofrequency catheter ablation

open access: yesBMC Cardiovascular Disorders, 2021
Background Elevated plasma carbohydrate antigen-125 (CA-125) levels are strongly associated with new-onset atrial fibrillation (AF) and heart failure, but the relationship between plasma CA-125 level and AF recurrence following radiofrequency catheter ...
Qingya Wang   +3 more
doaj   +1 more source

Masa Pélvica: características y forma de evaluación en el Instituto Oncológico Nacional.

open access: yesOncología, 2022
La masa pélvica es un proceso frecuente en mujeres cuyas edades están comprendidas entre los 10 a 70 años. La mayoría, en sus inicios no se acompañan de síntomas, por lo que es el médico, a través de la sospecha el que tiene que ordenar los exámenes ...
Jaime Sánchez S.   +3 more
doaj  

Tumor markers in heart failure [PDF]

open access: yesRomanian Journal of Medical Practice, 2016
It has been widely demonstrated that patients diagnosed with chronic heart failure present high levels of circulating neurohormones and inflammation markers which can secondarily induce an increase of the level of tumor markers such as CA 125, AFP, CEA ...
Nicolae BACALBASA   +4 more
doaj   +1 more source

Predictive Factors of Non-Elevation of Carcinoembryonic Antigen 125 in Acute Heart Failure

open access: yesLife
This study aims to analyze the factors associated with the lack of carbohydrate antigen 125 (CA-125) elevation in cases of acute heart failure (HF) decompensation.
Raquel López-Vilella   +8 more
doaj   +1 more source

Radioimmunoscintigraphy Using Monoclonal Antibodies to CEA, CA 19-9 and CA 125

open access: yesThe International Journal of Biological Markers, 1988
131 I labelled F (ab’) 2 fragments of monoclonal antibodies against CA 19-9 and CEA (“radioimmunococktail” IMACIS 1) were used in a prospective study (n = 60 patients) and in a retrospective study (n = 32 patients) for the detection of colorectal ...
R.P. Baum   +8 more
doaj   +1 more source

CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series

open access: yesGynecologic Oncology Reports, 2022
CA-125 has long been utilized as a surveillance biomarker for gynecologic malignancies but can be elevated in other conditions, including infection.
Susan M. Folsom   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy